diabetes-mellitus

Documents about diabetes-mellitus

• Structured Patient Education and Quality of Life of Elderly Patients With Diabetes Mellitus- a Prospective Study#143739ClinicalTrials.gov
• Artemether ameliorates type 1 diabetic liver injury alongside the associated defects in mitochondrial ultrastructure and central carbon metabolism#143880PLOS
• The Laparoscopic Transit Bipartition With Use Metalic Anastomosis Clip#154834ClinicalTrials.gov
• A Double-blind Study to Assess 2 Doses of an Investigational Product for 16 Weeks in Participants With Non-alcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus#162443ClinicalTrials.gov
• A Multi-Center, Randomized, Double-Blind, Phase III Trial to Evaluate the Safety and Efficacy of Saxagliptin Co-administered With Dapagliflozin Compared to Saxagliptin or Dapagliflozin All Given as add-on Therapy to Metformin in Subject With Type 2 Diabetes#18542ClinicalTrials.gov
• A Study Comparing the Injection Site Pain Experience After the Injection of Semaglutide B and Semaglutide D With 2 Different Injection Pens, a Compound for the Treatment of Type 2 Diabetes and Obesity#136247ClinicalTrials.gov
• Correlation Analysis of 24-h Minimum Heart Rate Levels and Deceleration Capacity of Heart Rate in Patients With Type 2 Diabetes Mellitus Complicated With Essential Hypertension.#28246NCBI PubMed Central
• A Study to Evaluate the Safety and Pharmacokinetics of UI087 Compared to Coadministration of UIC202506, UIC202507 and UIC202508 in Healthy Adult Volunteers Under Fasting Conditions#126029ClinicalTrials.gov
• Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study#6882OpenAlex
• A Study in Type 2 Diabetic Subjects on Stable Metformin Therapy to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Co-administering Single and Multiple Oral Doses of GSK1292263#28590ClinicalTrials.gov
• Bioequivalence Study of Sitagliptin Hydrochloride / Metformin Hydrochloride Extended-release Film Coated Tablets 50 mg /500 mg (FDC) in Healthy Adult Male and Female Subjects Under Fasting Conditions.#123408ClinicalTrials.gov
• Bioequivalence Study of Sitagliptin Hydrochloride / Metformin Hydrochloride Extended-release Film Coated Tablets 100 mg /1000 mg (FDC) in Healthy Adult Male and Female Subjects Under Fed Conditions.#140968ClinicalTrials.gov
• Remote Multichannel Monitoring of Patients With Chronic DIseAses Using Speech technoLogies Based On Artificial intelliGence#146295ClinicalTrials.gov
• Bioequivalence Study of Sitagliptin Hydrochloride / Metformin Hydrochloride Extended-release Film Coated Tablets 100 mg /1000 mg (FDC) in Healthy Adult Male and Female Subjects Under Fasting Conditions.#154860ClinicalTrials.gov
• Resistance Exercise and Low-Intensity Physical Activity Breaks in Sedentary Time to Improve Muscle and Cardiometabolic Health#158114ClinicalTrials.gov
• Investigation of the Rewarming og the Fingers After Cooling and the Autonomic Nervous System in Raynaud's Phenomenon#174987ClinicalTrials.gov
• General practice interventions to reduce cardiovascular disease risk in patients with severe mental illness: A scoping review#180459PLOS
• The mediating roles of personal mastery and health-promoting behaviors in the relationship between self-regulatory fatigue and quality of life among patients with type 2 diabetes mellitus.#193397NCBI PubMed Central
• Risk of Hypoglycemia in the Transition From Inpatient to Outpatient Setting. Comparative Study of Basal-bolus Insulin Versus Basal Insulin Plus GLP-1 Analogue#127784ClinicalTrials.gov
• Comparison of Safety and Efficacy of Needle-Free Injector and Insulin Pen in Patients With T2DM#162384ClinicalTrials.gov
• Tocilizumab for the Treatment of Cytokine Release Syndrome in Patients With COVID-19 (SARS-CoV-2 Infection)#181711ClinicalTrials.gov
• The impact of COVID-19 on longevity trends and disparities among Native Americans and Whites in the Four Corners States#197017PLOS
• Canagliflozin attenuates CMR-quantified myocardial fibrosis in individuals with type 2 diabetes mellitus at high cardiovascular risk: a randomised open-label controlled trial#130677Springer Nature OA
• Comparative Outcomes of One-Anastomosis Gastric Bypass and Roux-en-Y Gastric Bypass As Revisional Procedures Following Failed Restrictive Bariatric Surgery#172449ClinicalTrials.gov
• SGLT2 Inhibitors in Type 2 Diabetes Mellitus: A Comparative Review of Efficacy, Cardiovascular and Renal Benefits, and Cost#179740BYU ScholarsArchive
• The Non-high-density Lipoprotein Cholesterol (Non-HDL-C) to High-density Lipoprotein Cholesterol (HDL-C) Ratio (NHHR) and Its Association With Occurrence of Diabetic Nephropathy in Patients With Diabetes Mellitus#191575ClinicalTrials.gov
• Network toxicology and bioinformatics analysis predict potential molecular targets and mechanisms by which sevoflurane and propofol influence type 2 diabetes mellitus#197011PLOS
• A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Doses of JNJ-38431055, Sitagliptin, and Co-administration of JNJ-38431055 and Sitagliptin#123641ClinicalTrials.gov
• Development of a complex digital lifestyle intervention for individuals with prediabetes - Using the Medical research Council (MRC) framework.#9624PubMed
• A Comparison of Indapamide SR 1.5 mg With HCTZ 25 mg, in Combination With an ACE-inhibitor, in Patients With Mild to Moderate AHT and Type 2 DM#141135ClinicalTrials.gov
• A Study to Evaluate the Efficacy and Safety of Dual add-on Therapy With Gemigliptin 50 mg and Dapagliflozin 10 mg Added to Metformin Who Have Inadequate Glycemic Control on Metformin Alone#146420ClinicalTrials.gov
• Outcomes and factors associated with medical treatment failure in patients with spinal epidural abscess: A 14-year experience#154969PLOS
• Investigation of the Evolution of Gastric Emptying by Gastric Ultra Sonography in Patients Treated With GLP-1 Receptor Agonists on a 7 Days Pausing Period.#158144ClinicalTrials.gov
• Effects of Henagliflozin on the Brain Function in T2DM Patients With Mild Cognitive Impairment: a Randomized, Parallel Controlled Clinical Trial#160325ClinicalTrials.gov
• A Trial to Compare Blood Concentration Levels of Semaglutide Following Subcutaneous Injections of Semaglutide 1 mg by 2 Different Devices (the DV3372 Device and by the PDS290 Semaglutide Pen-injector)#180290ClinicalTrials.gov
• A Study to Evaluate the Food Effect on Drug Availability, Pharmacokinetic (PK) Properties, Safety and Tolerability of Two Different Dose Combination Therapy of Saxagliptin/Dapagliflozin/Metformin Extended-release (XR) Against Individual Component Co-administration.#136275ClinicalTrials.gov
• Determination of the Optimal Cut-Off Point of Anthropometric Indices to Predict the Risk of Metabolic Syndrome in Iranian Adult Population With Type 2 Diabetes Mellitus: A Cross-Sectional-Analytical Study.#193756NCBI PubMed Central
• Comparative evaluation of oxidative stress biomarkers F2-isoprostanes and 8-OHdG in Parkinson’s disease and Type 2 Diabetes Mellitus: a systematic review and meta-analysis of human studies#130449Unpaywall
• Le travail du patient diabétique dans la trajectoire de la maladie au Brésil et en France : regards croisés.#126782HAL (France)
• Baseline RDW combined with dynamic trajectory: Predictive value for 30-day all-cause mortality in patients with sepsis-induced coagulopathy and development of a nomogram#138712PLOS
• Truway Diagnostic Tools in Primary Care#148700ClinicalTrials.gov
• Identification of risk areas and associated factors of unfavorable treatment outcomes in drug-resistant tuberculosis: Evidence from Rio de Janeiro, Brazil#162580PLOS
• Relación entre la adicción a los alimentos hiperpalatables y el control metabólico en pacientes adultos con Diabetes Mellitus 2 del Hospital Padre Hurtado#188607Repositorio Universidad del Desarrollo
• PPIO-007 Correlation Analysis of Type II Diabetes Mellitus on Short-term and Long-term Outcomes of Patients With Esophageal Squamous Cell Cancer Undergoing Minimally Invasive Esophagectomy#67809ClinicalTrials.gov
• Rôle des Espèces Réactives de l’Oxygène (ROS) : du stress nucléolaire induit par EBNA-1 au contrôle de l'inflammation par la lumière proche infrarouge sur modèles infectieux et métaboliques#142479HAL (France)
• An Open-label, Randomized, Crossover Study of Comparative Pharmacokinetics and Bioequivalence of Dapagliflozin + Metformin, 10 mg + 1000 mg Versus the Combined Use of Forxiga™, 10 mg and Two Glucophage® Long, ER Tablets, 500 mg Co-administered to Healthy Volunteers Under Standard Fed Conditions#195538ClinicalTrials.gov
• A Prospective Randomnised Controlled Trial Comparing Overall Patient Compliance in a Bariatric Surgical Pathway Using the Standard Versus a More Intensified and Interactive Version of the "Get Ready" Smartphone Application.#154804ClinicalTrials.gov
• A Clinical Trial to Investigate Safety/Tolerability and Pharmacokinetics of DA-1229_01(Evogliptin/Metformin XR 2.5/500 mg x 2 Tablets) Compared to Co-administration of Evogliptin 5 mg and Metformin XR 1000 mg in Healthy Male Volunteers#180330ClinicalTrials.gov
• Relación entre adicción a los alimentos hiperpalatables y niveles de severidad de depresión en adultos diabéticos tipo 2 atendidos en el programa de rehabilitación cardiovascular del Hospital Padre Hurtado durante el 2025#190516Repositorio Universidad del Desarrollo
• Clinical Trial Investigating the Effect of Exosomes as a Complementary Treatment in Severe to Moderate Erectile Dysfunction#195462ClinicalTrials.gov